| ADR Ontology |
| ADR Term |
Mastocytosis |
| ADR ID |
BADD_A02670 |
| ADR Hierarchy |
|
| Description |
A heterogenous group of disorders characterized by the abnormal increase of MAST CELLS in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA). [MeSH] |
| MedDRA Code |
10026891 |
| MeSH ID |
D008415
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Mastocytosis | Mast cell aggregation | Mastocytoses | Mast Cell Activation Syndrome | Mast Cell Activation Disease | Mast Cell Activation Syndromes | Mast Cell Disease | Mast Cell Diseases | Mast-Cell Disease | Mast-Cell Diseases |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01136 | Imatinib | 0.000533% | | | BADD_D01300 | Lisinopril | 0.000021% | | | BADD_D02392 | Zoledronic acid | 0.019683% | |
| The 1th Page 1
Total 1 Pages
|
|
